Merck Millipore celebrates 40 years of first class sterility testing solutions - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Merck Millipore celebrates 40 years of first class sterility testing solutions

In 1974, Merck Millipore was the first to market a closed filtration device: Steritest™. Since this time, through dedicated research & development, we have been instrumental in raising the industry's standards – reducing the risk of false positive and negative results, increasing reliability and improving workflow for microbiologists around the world.

We are a one-stop shop that offers an extensive portfolio of quality control products, as well as preventive maintenance, training, validation support and much more.
As we step into the future, Merck Millipore will continue providing reliable high quality products and comprehensive first-class services.

Our latest offer: a rapid sterility testing solution providing results within only 5 days.

40 years is just the beginning

www.merckmillipore.com/40years-steritest

“Conducting a test for sterility requires excellent work flows and a reliable test performance. The Merck Millipore SteritestTM system, with pump and filtration devices, supports the operators in a perfect manner to obtain reliable test results.”

Dr. Timo Krebsbach, Divison Manager Marketing & Sales, Labor L+S AG

 

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
FindPharma Custom Search

Click here